Journal of Affective Disorders
Volume 70, Issue 2 , Pages 125-132 , July 2002

Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women: The Harvard Study of Moods and Cycles

  • Lee S Cohen

      Affiliations

    • Harvard Medical School, Boston, MA, USA
    • Perinatal and Reproductive Psychiatry Clinical Research Program, Massachusetts General Hospital—Harvard Medical School, 15 Parkman Street WACC 815, Boston, MA 02114, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-617-724-8020; fax: +1-617-726-7541
  • ,
  • Claudio N Soares

      Affiliations

    • Harvard Medical School, Boston, MA, USA
    • Perinatal and Reproductive Psychiatry Clinical Research Program, Massachusetts General Hospital—Harvard Medical School, 15 Parkman Street WACC 815, Boston, MA 02114, USA
  • ,
  • Michael W Otto

      Affiliations

    • Harvard Medical School, Boston, MA, USA
  • ,
  • Bernadette H Sweeney

      Affiliations

    • Perinatal and Reproductive Psychiatry Clinical Research Program, Massachusetts General Hospital—Harvard Medical School, 15 Parkman Street WACC 815, Boston, MA 02114, USA
  • ,
  • Rebecca F Liberman

      Affiliations

    • Obstetrics and Gynecology Epidemiology Center, Brigham and Women’s Hospital, Boston, MA, USA
  • ,
  • Bernard L Harlow

      Affiliations

    • Harvard Medical School, Boston, MA, USA
    • Obstetrics and Gynecology Epidemiology Center, Brigham and Women’s Hospital, Boston, MA, USA

Received 4 June 2001 ,Revised 25 September 2001 ,Accepted 3 November 2001.

References 

  1. American Psychiatric Association . PMDD Symptoms. 4th Edition. Washington, DC: American Psychiatric Association; 1994;
  2. Bailey JW, Cohen LS. Prevalence of mood and anxiety disorders in women who seek treatment for premenstrual syndrome. J. Womens Health Gend. Based Med. 1999;8:1181–1184
  3. Bancroft J, Rennie D, Warner P. Vulnerability to perimenstrual mood change: the relevance of a past history of depressive disorder. Psychosom. Med. 1994;56:225–231
  4. Brown RA, Lewinsohn PM, Seeley JR, Wagner EF. Cigarette smoking, major depression, and other psychiatric disorders among adolescents. J. Am. Acad. Child Adolesc. Psychiatry. 1996;35:1602–1610
  5. Campbell EM, Peterkin D, O’Grady K, Sanson-Fisher R. Premenstrual symptoms in general practice patients: prevalence and treatment. J. Reprod. Med. 1997;42:637–646
  6. Chang AM, Holroyd E, Chau JP. Premenstrual syndrome in employed Chinese women in Hong Kong. Health Care Women Int. 1995;16:551–561
  7. Coryell W, Endicott J, Keller M. Major depression in a nonclinical sample. Demographic and clinical risk factors for first onset. Arch. Gen. Psychiatry. 1992;49:117–125
  8. Endicott J, Harrison W. Daily Rating of Severity of Problems Form. New York: Department of Research Assessment and Training, New York State Psychiatric Institute; 1990;
  9. Endicott J, Amsterdam J, Eriksson E, Frank E, Freeman E, Hirschfeld R, et al.  Is premenstrual dysphoric disorder a distinct clinical entity?. J. Womens Health Gend. Based Med. 1999;8(5):663–679
  10. Fava M, Pedrazzi F, Guaraldi GP. Comorbid anxiety and depression among patients with late luteal phase dysphoric disorder. J. Anxiety Disord. 1992;6:325–335
  11. Graze KK, Nee J, Endicott J. Premenstrual depression predicts future major depressive disorder. Acta Psychiatr. Scand. 1990;81:201–205
  12. Hargrove JT, Abraham GE. The incidence of premenstrual tension in a gynaecological clinic. J. Reprod. Med. 1982;27:721–724
  13. Harlow BL, Cohen LS, Otto MW, Spiegelman D, Cramer DW. Prevalence and predictors of depressive symptoms in older premenopausal women. Arch. Gen. Psychiatry. 1999;56:418–424
  14. Harlow B.L., Cohen L.S., Otto M.W., Liberman R.F., Spiegelman D., Cramer D.W., 2001. Demographic, family, and occupational characteristics associated with major depression: The Harvard Study of Moods and Cycles. Am. J. Epidemiol. (in press).
  15. Harrison WM, Endicott J, Nee J, Glick H, Rabkin JG. Characteristics of women seeking treatment for premenstrual syndrome. Psychosomatics. 1989;30:405–411
  16. Hurt SW, Schnurr PP, Severino SK, Freeman EW, Gise LH, Rivera-Tovar A, et al. Late luteal phase dysphoric disorder in 670 women evaluated for premenstrual complaints. Am. J. Psychiatry. 1992;149:525–530
  17. Hylan TR, Sundell K, Judge R. The impact of premenstrual symptomatology on functioning and treatment-seeking behavior: experience from the United States, United Kingdom and France. J. Womens Health Gend. Based Med. 1999;8:1043–1052
  18. Johnson SR, McChesney C, Bean JA. Epidemiology of premenstrual symptoms in a non-clinical sample. I. Prevalence, natural history and help-seeking behavior. J. Reprod. Med. 1988;33:340–346
  19. Kuczmierczyk AR, Labrum AH, Johnson CC. Perception of family and work environments in women with premenstrual syndrome. Psychosom. Res. 1992;36:787–795
  20. Marvan ML, Diaz-Erosa M, Montesinos A. Premenstrual symptoms in Mexican women with different educational levels. J. Psychol. 1998;132:517–526
  21. Moos RH. Typology of menstrual cycle symptoms. Am. J. Obstet. Gynecol. 1969;103:390–402
  22. Novaes C, Almeida OP, de Melo NR. Mental health among perimenopausal women attending a menopause clinic: possible association with premenstrual syndrome?. Climacteric. 1998;1:264–270
  23. Patton GC, Hibbert ME, Carlin J, Shao Q, Rosier M, Caust J, et al.  Menarche and the onset of depression and anxiety in Victoria, Australia. J. Epidemiol. Commun. Med. 1996;50:661–666
  24. Pearlstein TB, Halbreich U, Batzar ED, Brown CS, Endicott J, Frank E, et al.  Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo. J. Clin. Psychiatry. 2000;61:101–109
  25. Perez-Stable EJ, Marin G, Marin BV, Katz MH. Depressive symptoms and cigarette smoking among Latinos in San Francisco. Am. J. Public Health. 1990;80:1500–1502
  26. Rivera-Tovar AD, Frank E. Late luteal phase dysphoric disorder in young women. Am. J. Psychiatry. 1990;147:1634–1636
  27. SAS Institute . SAS/STAT User’s Guide, Version 6. 4th Edition. Cary, NC: SAS Institute Inc; 1990;
  28. Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. New Engl. J. Med. 1998;338:209–216
  29. Spitzer RL, Williams JB, Gibbon M. Structured Clinical Interview for DSM III-R. Patient Edition. New York: Biometric Research, New York State Psychiatric Institute; 1990;
  30. Steinberg S. The treatment of late luteal phase dysphoric disorder. Life Sci. 1991;49:767–802
  31. Steiner M, Born L. Diagnosis and treatment of premenstrual dysphoric disorder: an update. Int. Clin. Psychopharmacol. 2000;15(Suppl.):S3–S17
  32. Stout AL, Steege JF, Blazer DG, George LK. Comparison of lifetime diagnosis in premenstrual syndrome clinic and community samples. J. Nerv. Ment. Dis. 1986;174:517–521
  33. Wood C, Larsen L, Williams R. Menstrual characteristics of 2343 women attending the Shepard Foundation. Aust. NZ J. Obstet. Gynaecol. 1979;19:107–110
  34. Woods NF, Dery GK, Most A. Stressful life events and perimenstrual symptoms. J. Hum. Stress. 1982;8:23–31
  35. Zhao G, Wang L, Qu C. Prevalence of premenstrual syndrome in reproductive women and its influential factors. Chung Hua Fu Chan Ko Tsa Chih. 1998;33:222–224

PII: S0165-0327(01)00458-X

Journal of Affective Disorders
Volume 70, Issue 2 , Pages 125-132 , July 2002